For 5th Time, Flynas Wins Skytrax Award as Middle East's Best Low-Cost Airline

A flynas Airbus A320 aircraft on the tarmac at Cairo International Airport. (AFP)
A flynas Airbus A320 aircraft on the tarmac at Cairo International Airport. (AFP)
TT

For 5th Time, Flynas Wins Skytrax Award as Middle East's Best Low-Cost Airline

A flynas Airbus A320 aircraft on the tarmac at Cairo International Airport. (AFP)
A flynas Airbus A320 aircraft on the tarmac at Cairo International Airport. (AFP)

Flynas, the Saudi air carrier and the leading low-cost airline in the Middle East, won the Skytrax Award as the Best Low-Cost Airline in the Middle East for the fifth consecutive year at a forum held in London on Friday, reported the Saudi Press Agency.

The Skytrax Award, launched in 1999, is the highest award in the aviation industry and the most important global standard for excellence among airlines worldwide.

Bander Almohanna, CEO of Flynas, said: “The crowning of Flynas for the fifth year in a row as the Best Low-Cost Airline in the Middle East with the Skytrax Award in the most important global forum for the aviation industry confirms our leadership as a national air carrier that raises the name of the Kingdom high on its National Day, and achieves the goals of Saudi Vision 2030 and the Strategy for the Civil Aviation Sector in Saudi Arabia.”

He stressed that this win reflects Flynas’ commitment to operational excellence and meeting the aspirations of its traveling guests. It is also in line with achieving its growth and expansion strategy under the title “We Connect the World to the Kingdom,” which included launching more than 16 new destinations in 2022, bringing the number of Flynas destinations to more than 70 domestic and international destinations.

“Flynas fleet continues to grow, as it reached 38 aircraft in the first half of 2022 and will increase to 52 aircraft by the end of 2023,” said Almohanna.

“In addition, the Flynas Board of Directors approved to increase the purchase order for new aircraft to 250 aircraft, in an effort to participate effectively in achieving the Strategy for the Civil Aviation Sector in Saudi Arabia, which aims to reach 300 million passengers and connect the Kingdom with 250 international destinations by 2030,” he added.

The Skytrax Awards are awarded after a multi-month evaluation that includes more than 100 countries; by conducting the largest survey of its kind to measure passengers’ satisfaction in the world annually.

By winning the award for this year, Flynas now has five awards from Skytrax as the Best Low-Cost Airline in the Middle East in the years 2017, 2018, 2019, 2021, and 2022.

Flynas has achieved the highest rating in the Official Airline Rating conducted by the non-profit organization APEX, which is one of the most significant associations of airlines worldwide.

In the assessment that included 600 companies globally, Flynas was ranked in the 4-star low-cost carrier category, the highest category of low-cost airlines.

Moreover, Flynas has been ranked as the Leading Low-Cost Airline in the Middle East by the World Travel Awards for seven consecutive years.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.